Spinal Muscular Atrophy
Delivery Method for SMA Drug Nusinersen Evaluated for Safety and Efficacy
A new, more streamlined method of administration has recently been developed for the use of nusinersen in Spinal muscular atrophy (SMA).
A new, more streamlined method of administration has recently been developed for the use of nusinersen in Spinal muscular atrophy (SMA).
NICE issued a draft guidance recommending the use of risdiplam as a new drug treatment for spinal muscular atrophy (SMA)
A pilot program in Australia looked at at the importance of testing for spinal muscular atrophy (SMA) in newborns.
Spinal muscular atrophy is a debilitating rare illness, but advances in gene therapy might prove to be the future of treatment.